Brief: Indrayani Biotech Says Unit IBL Healthcare Invested In Kniss Laboratories By Subscribing To Equity Shares Of Co
25/08/2023 14:46
Aug 25 (Reuters) - Indrayani Biotech Ltd INBT.BO :
* UNIT IBL HEALTHCARE INVESTED IN KNISS LABORATORIES BY
SUBSCRIBING TO EQUITY SHARES OF CO
* COST OF ACQUISITION 54.7 MILLION RUPEES
Source text for Eikon: ID:nBSEb4sN15
Further company coverage: INBT.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Indrayani Biotech
See all newsBrief: Indrayani Biotech Says Board Discusses Preliminary Demerger Proposal For Food Division
Brief: Indrayani Biotech Ltd Board To Deliberate Demerger Proposal For Unit Into Separate Entity
Brief: Indrayani Biotech Says CFO Vinayaka Bodala Resigns
Brief: Indrayani Biotech To Consider Issue Of Shares Via Rights Issue
Brief: Indrayani Biotech Says IBL Healthcare Disinvested 52,970 Equity Shares Of IHHC